107 related articles for article (PubMed ID: 4034954)
1. Brain tumors: detection and typing by use of CPMG sequences and in vivo T2 measurements.
Rinck PA; Meindl S; Higer HP; Bieler EU; Pfannenstiel P
Radiology; 1985 Oct; 157(1):103-6. PubMed ID: 4034954
[TBL] [Abstract][Full Text] [Related]
2. [Magnetic resonance in the study of cerebral gliomas].
Vaghi MA; Visciani A; Passerini A; Longone V; Broggi G
Radiol Med; 1986 Jun; 72(6):431-8. PubMed ID: 3012662
[TBL] [Abstract][Full Text] [Related]
3. Calculation of T2 relaxation time from ultrafast single shot sequences for differentiation of liver tumors: comparison of echo-planar, HASTE, and spin-echo sequences.
Abe Y; Yamashita Y; Tang Y; Namimoto T; Takahashi M
Radiat Med; 2000; 18(1):7-14. PubMed ID: 10852650
[TBL] [Abstract][Full Text] [Related]
4. T2 estimates in healthy and diseased brain tissue: a comparison using various MR pulse sequences.
Darwin RH; Drayer BP; Riederer SJ; Wang HZ; MacFall JR
Radiology; 1986 Aug; 160(2):375-81. PubMed ID: 3726116
[TBL] [Abstract][Full Text] [Related]
5. Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET.
Luyten PR; Marien AJ; Heindel W; van Gerwen PH; Herholz K; den Hollander JA; Friedmann G; Heiss WD
Radiology; 1990 Sep; 176(3):791-9. PubMed ID: 2389038
[TBL] [Abstract][Full Text] [Related]
6. In vivo sodium-23 MRI in brain tumors: evaluation of preliminary clinical experience.
Hashimoto T; Ikehira H; Fukuda H; Yamaura A; Watanabe O; Tateno Y; Tanaka R; Simon HE
Am J Physiol Imaging; 1991; 6(2):74-80. PubMed ID: 1867865
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
8. Experimental and human brain neoplasms: detection with in vivo sodium MR imaging.
Turski PA; Houston LW; Perman WH; Hald JK; Turski D; Strother CM; Sackett JF
Radiology; 1987 Apr; 163(1):245-9. PubMed ID: 3029803
[TBL] [Abstract][Full Text] [Related]
9. Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas?
Pauleit D; Langen KJ; Floeth F; Hautzel H; Riemenschneider MJ; Reifenberger G; Shah NJ; Müller HW
J Magn Reson Imaging; 2004 Nov; 20(5):758-64. PubMed ID: 15503327
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of brain tumor with proton MR spectroscopy--the quantification of gliomas compared with normal brain].
Yu HW; Tanabe S; Yamaki T; Harada K; Hashi K
No Shinkei Geka; 2000 Dec; 28(12):1063-9. PubMed ID: 11193526
[TBL] [Abstract][Full Text] [Related]
11. [Initial clinical results of tissue characterization by T1, T2 and proton density in nuclear magnetic resonance tomography].
Pfannenstiel P; Just M; Higer HP; Bielke G; Meindl S; Jungke M; Grigat M; Straube U; von Seelen W; Voth D
Rofo; 1987 May; 146(5):591-6. PubMed ID: 3035649
[TBL] [Abstract][Full Text] [Related]
12. Relationship between contrast enhancement on fluid-attenuated inversion recovery MR sequences and signal intensity on T2-weighted MR images: visual evaluation of brain tumors.
Kubota T; Yamada K; Kizu O; Hirota T; Ito H; Ishihara K; Nishimura T
J Magn Reson Imaging; 2005 Jun; 21(6):694-700. PubMed ID: 15906343
[TBL] [Abstract][Full Text] [Related]
13. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
Hourani R; Horská A; Albayram S; Brant LJ; Melhem E; Cohen KJ; Burger PC; Weingart JD; Carson B; Wharam MD; Barker PB
J Magn Reson Imaging; 2006 Feb; 23(2):99-107. PubMed ID: 16374884
[TBL] [Abstract][Full Text] [Related]
14. [MR tomography of astrocytic tumors (I-III)].
Pedrosa P; Grigat M; Higer HP; Straube U; Schaeben W; Gutjahr P; Voth D; Kunze S
Rofo; 1989 Jan; 150(1):52-7. PubMed ID: 2536497
[TBL] [Abstract][Full Text] [Related]
15. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
[TBL] [Abstract][Full Text] [Related]
16. Hemorrhagic intracranial malignant neoplasms: spin-echo MR imaging.
Atlas SW; Grossman RI; Gomori JM; Hackney DB; Goldberg HI; Zimmerman RA; Bilaniuk LT
Radiology; 1987 Jul; 164(1):71-7. PubMed ID: 3588929
[TBL] [Abstract][Full Text] [Related]
17. [Magnetic resonance tomography of intracranial tumors: use of contrast media versus T2-weighted tomograms].
Schörner W; Laniado M; Claussen C; Kazner E; Niendorf HP; Felix R
Rofo; 1986 Mar; 144(3):315-22. PubMed ID: 3008234
[TBL] [Abstract][Full Text] [Related]
18. Expression forms and characteristics of Carr-Purcell-Meiboom-Gill sequence magnetic resonance images.
Yamada S; Matsuzawa T; Yamada K; Ono S; Hishinuma T
Tohoku J Exp Med; 1989 Mar; 157(3):185-92. PubMed ID: 2727986
[TBL] [Abstract][Full Text] [Related]
19. Dependence of transverse relaxation time T2 of biologic tissues on the interpulse delay time in Carr-Purcell-Meiboom-Gill (CPMG) measurements.
Shioya S; Kurita D; Haida M; Fukuzaki M; Tanigaki T; Kutsuzawa T; Ohta Y
Tokai J Exp Clin Med; 1997 May; 22(2):27-31. PubMed ID: 9608628
[TBL] [Abstract][Full Text] [Related]
20. Gd-DTPA in clinical MR of the brain: 1. Intraaxial lesions.
Brant-Zawadzki M; Berry I; Osaki L; Brasch R; Murovic J; Norman D
AJR Am J Roentgenol; 1986 Dec; 147(6):1223-30. PubMed ID: 3490758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
